Skip to main content

Viridian Therapeutics, Inc.

VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001590750

In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Viridian Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
55
+17 vs. Q3 2021
Shares held
23.3M
+9.73M (+72.0%) vs. Q3 2021
Total value
$459.8M
+$237.4M (+106.7%) vs. Q3 2021
New holders
20
22 more added
Sold out
3
6 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 55 institutions
Q1 2021: 33 institutionsQ2 2021: 26 institutionsQ3 2021: 39 institutionsQ4 2021: 55 institutionsQ1 2022: 72 institutionsQ2 2022: 84 institutionsQ3 2022: 105 institutionsQ4 2022: 122 institutionsQ1 2023: 135 institutionsQ2 2023: 128 institutionsQ3 2023: 124 institutionsQ4 2023: 132 institutionsQ1 2024: 136 institutionsQ2 2024: 138 institutionsQ3 2024: 165 institutionsQ4 2024: 179 institutionsQ1 2025: 177 institutionsQ2 2025: 171 institutionsQ3 2025: 169 institutionsQ4 2025: 229 institutionsQ1 2026: 225 institutionsQ2 2026: 214 institutions
Value heldQ4 2021: $459.8M
Q1 2021: $84.5MQ2 2021: $109.8MQ3 2021: $223.7MQ4 2021: $459.8MQ1 2022: $460.9MQ2 2022: $327.7MQ3 2022: $778.5MQ4 2022: $1.21BQ1 2023: $1.10BQ2 2023: $1.12BQ3 2023: $769.9MQ4 2023: $1.31BQ1 2024: $1.24BQ2 2024: $906.2MQ3 2024: $1.98BQ4 2024: $1.75BQ1 2025: $1.23BQ2 2025: $1.32BQ3 2025: $2.01BQ4 2025: $3.36BQ1 2026: $2.21BQ2 2026: $2.50B
Institutions holding VRDN and their total value by quarter
QuarterHoldersValue
Q2 2026214$2.50B
Q1 2026225$2.21B
Q4 2025229$3.36B
Q3 2025169$2.01B
Q2 2025171$1.32B
Q1 2025177$1.23B
Q4 2024179$1.75B
Q3 2024165$1.98B
Q2 2024138$906.2M
Q1 2024136$1.24B
Q4 2023132$1.31B
Q3 2023124$769.9M
Q2 2023128$1.12B
Q1 2023135$1.10B
Q4 2022122$1.21B
Q3 2022105$778.5M
Q2 202284$327.7M
Q1 202272$460.9M
Q4 202155$459.8M
Q3 202139$223.7M
Q2 202126$109.8M
Q1 202133$84.5M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding VRDN in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Group AG13$00.00%−1,430−99.1%Reduced
GPS Wealth Strategies Group, LLC3$00.00%00.0%Unchanged
Tower Research Capital LLC (TRC)1$00.00%+1New
Wells Fargo & Company486$9.00K0.00%+74+18.0%Added
Bank of America Corp9,514$188.0K0.00%+9,341+5,399.4%Added
Sender Co & Partners, Inc.12,216$242.0K0.15%+12,216New
PDT Partners, LLC12,615$249.0K0.02%+12,615New
JPMorgan Chase & Co13,033$258.0K0.00%+13,033New
Morgan Stanley13,695$271.0K0.00%+3,773+38.0%Added
Citigroup Inc14,884$294.0K0.00%+14,884New
Qube Research & Technologies Ltd17,000$336.0K0.00%+17,000New
Atom Investors LP18,884$373.0K0.10%+18,884New
Schonfeld Strategic Advisors LLC21,512$425.0K0.00%−22,488−51.1%Reduced
683 Capital Management, LLC21,628$428.0K0.02%+21,628New
Maven Securities LTD21,951$434.0K0.05%−118,049−84.3%Reduced
State Street Corp34,041$673.0K0.00%+10,200+42.8%Added
LMR Partners LLP41,400$818.0K0.01%+7,892+23.6%Added
Driehaus Capital Management LLC50,000$989.0K0.01%00.0%Unchanged
Northern Trust Corp59,328$1.17M0.00%+24,677+71.2%Added
Polar Asset Management Partners Inc.59,700$1.18M0.01%00.0%Unchanged
Endurant Capital Management LP67,450$1.33M0.36%+67,450New
ExodusPoint Capital Management, LP76,757$1.52M0.02%+76,757New
Marshall Wace, LLP88,405$1.75M0.00%+88,405New
Soleus Capital Management, L.P.90,000$1.78M0.24%+90,000New
Atlas Venture Life Science Advisors, LLC90,072$1.78M0.16%+90,072New
Pura Vida Investments, LLC104,860$2.07M0.22%+46,764+80.5%Added
Walleye Capital LLC110,175$2.18M0.07%+87,674+389.6%Added
Silverarc Capital Management, LLC123,806$2.45M1.10%+17,728+16.7%Added
BlackRock Inc.153,126$3.03M0.00%+102,285+201.2%Added
Eversept Partners, LP194,589$3.85M0.32%+34,589+21.6%Added
Geode Capital Management, LLC201,678$3.99M0.00%+140,428+229.3%Added
Atlas Venture Advisors, Inc.209,505$4.14M0.58%00.0%Unchanged
Woodline Partners LP257,670$5.09M0.07%+257,670New
Kynam Capital Management, LP287,934$5.69M3.04%+287,934New
Cormorant Asset Management, LP300,000$5.93M0.35%−42,562−12.4%Reduced
Acuta Capital Partners, LLC318,000$6.29M2.64%+182,193+134.2%Added
Millennium Management LLC462,390$9.14M0.01%+301,045+186.6%Added
Point72 Asset Management, L.P.472,864$9.35M0.04%−137,136−22.5%Reduced
Ghost Tree Capital, LLC500,000$9.88M3.79%+150,000+42.9%Added
Franklin Resources Inc600,023$11.9M0.00%+230.0%Added
Ally Bridge Group (NY) LLC604,774$12.0M4.18%−300,204−33.2%Reduced
D. E. Shaw & Co., Inc.764,613$15.1M0.02%+44,083+6.1%Added
Commodore Capital LP847,683$16.8M3.88%+180,009+27.0%Added
Vanguard Group Inc925,676$18.3M0.00%+463,764+100.4%Added
Citadel Advisors LLC943,340$18.6M0.02%+943,340New
Fairmount Funds Management LLC944,092$18.7M6.15%00.0%Unchanged
Paradigm Biocapital Advisors LP1,209,051$23.9M6.83%+1,209,051New
Avidity Partners Management LP1,278,261$25.3M0.54%+1,278,261New
Vivo Capital, LLC1,300,000$25.7M1.55%00.0%Unchanged
TCG Crossover Management, LLC1,314,000$26.0M12.16%+1,314,000New
Deep Track Capital, LP1,336,690$26.4M1.95%+1,336,690New
Perceptive Advisors LLC1,423,053$28.1M0.43%+530.0%Added
Frazier Management LLC1,505,200$29.8M2.29%00.0%Unchanged
VR Adviser, LLC1,852,919$36.6M5.01%+1,833,424+9,404.6%Added
BVF Inc1,879,412$37.2M1.35%+1,075,286+133.7%Added
Logos Global Management LP0$00.00%−1,500,000−100.0%Sold out
Walleye Trading LLC0$00.00%−7,500−100.0%Sold out
Ra Capital Management, L.P.0$00.00%−1,034−100.0%Sold out
Marshall Wace North America L.P.––––Not filed